Please klick on the PDF-icon to view newspage or use link.
May 15, 2008
Terguride receives FDA orphan drug designation for the treatment of pulmonary arterial hypertension
January 29, 2008
ErgoNex Pharma initiates Phase IIb clinical trial of Terguride in pulmonary arterial hypertension.